<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR Phase I: Label Free Nucleic Acid Assays for POC Diagnostics</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>01/01/2009</AwardEffectiveDate>
<AwardExpirationDate>12/31/2009</AwardExpirationDate>
<AwardTotalIntnAmount>0.00</AwardTotalIntnAmount>
<AwardAmount>99745</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>15030000</Code>
<Directorate>
<Abbreviation>TIP</Abbreviation>
<LongName>Dir for Tech, Innovation, &amp; Partnerships</LongName>
</Directorate>
<Division>
<Abbreviation>TI</Abbreviation>
<LongName>Translational Impacts</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Gregory T. Baxter</SignBlockName>
<PO_EMAI/>
<PO_PHON/>
</ProgramOfficer>
<AbstractNarration>This Small Business Innovation Research (SBIR) Phase I project proposes to develop a Label Free Nucleic Acid Assay for Point-Of-Care (POC) Diagnostics especially for Sexually Transmitted Infections (STI).&lt;br/&gt;&lt;br/&gt;The broader impacts of this research are to enable effective diagnosis and treatment of chlamydia and gonorrhoeae in a single visit at the clinic and thus avoid patients who currently go untreated because they are lost-to-follow-ups. The ability to obtain easily available POC tests in primary care clinics, school clinics, Emergency Department settings, or even at-home testing (OTC), may have a far reaching impact on the rates of STIs in this country.</AbstractNarration>
<MinAmdLetterDate>11/06/2008</MinAmdLetterDate>
<MaxAmdLetterDate>05/29/2009</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.084</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>0839323</AwardID>
<Investigator>
<FirstName>Kumar</FirstName>
<LastName>Subramanian</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Kumar Subramanian</PI_FULL_NAME>
<EmailAddress>kumar@phoenixbiosystem.com</EmailAddress>
<PI_PHON>9259985075</PI_PHON>
<NSF_ID>000155847</NSF_ID>
<StartDate>11/06/2008</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Phoenix Biosystems</Name>
<CityName>Pleasanton</CityName>
<ZipCode>945668616</ZipCode>
<PhoneNumber>9258580484</PhoneNumber>
<StreetAddress>6833 Corte Munras</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<StateCode>CA</StateCode>
<CONGRESSDISTRICT>15</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>CA15</CONGRESS_DISTRICT_ORG>
<ORG_UEI_NUM>NXDUD4NDDQ93</ORG_UEI_NUM>
<ORG_LGL_BUS_NAME>PHOENIX BIOSYSTEM, INC.</ORG_LGL_BUS_NAME>
<ORG_PRNT_UEI_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[Phoenix Biosystems]]></Name>
<CityName>Pleasanton</CityName>
<StateCode>CA</StateCode>
<ZipCode>945668616</ZipCode>
<StreetAddress><![CDATA[6833 Corte Munras]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>15</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>CA15</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<FoaInformation>
<Code>0308000</Code>
<Name>Industrial Technology</Name>
</FoaInformation>
<ProgramElement>
<Code>5371</Code>
<Text>SBIR Phase I</Text>
</ProgramElement>
<ProgramReference>
<Code>1167</Code>
<Text>MULTIDISCIPLINARY BIOTECHNOLOGY</Text>
</ProgramReference>
<ProgramReference>
<Code>9107</Code>
<Text>BIOELECTRONICS AND BIONETWORKS</Text>
</ProgramReference>
<ProgramReference>
<Code>BIOT</Code>
<Text>BIOTECHNOLOGY</Text>
</ProgramReference>
<Appropriation>
<Code>0109</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<Fund>
<Code>01000910DB</Code>
<Name><![CDATA[NSF RESEARCH & RELATED ACTIVIT]]></Name>
<FUND_SYMB_ID>040100</FUND_SYMB_ID>
</Fund>
<FUND_OBLG>2009~99745</FUND_OBLG>
</Award>
</rootTag>
